Full-Time

Associate Director

Field Medical Advisor

Posted on 5/5/2025

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines for health

No salary listed

Mid, Senior

Remote in UK

Candidates must be based in the UK.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • Advanced scientific degree required – MD, PharmD
  • Minimum of 4 years’ experience in Medical Affairs or field medical roles
  • Experience of being a Final Signatory of the ABPI code of practice.
Responsibilities
  • Develop and implement tailored Scientific Engagement Plans that align with Moderna's strategy and the healthcare ecosystem.
  • Utilise exceptional communication skills to simplify complex scientific topics for diverse audiences, leveraging tools like Moderna's Scientific Communications Platform and generative AI.
  • Gather and analyze medical intelligence to understand the “what,” “why,” “who,” and “where” of healthcare challenges.
  • Building and maintaining relationships with key stakeholders, including Key Opinion Leaders, public health institutions, and patient advocacy groups.
  • Sharing up-to-date clinical trial data and research findings across Moderna’s therapeutic areas.
  • Driving initiatives that enhance patient care and outcomes through collaboration with healthcare professionals and systems.
  • Executing medical engagement activities, such as advisory boards and conferences, and navigating processes related to Fellowships, Grants, and Investigator Sponsored Studies.
  • Ensuring compliance with the ABPI Code of Practice and serving as a Final Signatory when required.
Desired Qualifications
  • Experience in medical affairs and / or clinical development and / or market access, preferably with vaccines, immunology or infectious diseases.
  • Established relationships within the medical community and a strong understanding of healthcare ecosystems.
  • Demonstrated ability to navigate compliance frameworks and interact ethically within a field-based role.
  • Exceptional communication, problem-solving, and relationship-building skills.
  • Business proficiency in English
  • Willing to travel up to 75%
  • Proficiency in digital technology and familiarity with virtual presentation platforms and Microsoft Office Suite.

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a crucial component in how cells produce proteins necessary for biological functions. Their approach involves creating a new class of medicines that utilize mRNA to instruct cells to produce specific proteins, potentially leading to significant advancements in treating diseases. Unlike traditional methods of drug development, Moderna's use of mRNA allows for a more flexible and efficient process in discovering and manufacturing medicines. The company's goal is to harness the power of mRNA to improve patient outcomes and create a new category of therapies that can address various health challenges.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Cambridge, Massachusetts

Founded

2010

Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna's RSV vaccine received regulatory approval in Australia, expanding its infectious disease portfolio.
  • The collaboration with Merck on personalized cancer vaccines shows promising early trial results.
  • Moderna's mRNA technology is gaining traction in personalized medicine and infectious disease prevention.

What critics are saying

  • Moderna faces reputational damage from a bribery scandal related to COVID-19 vaccine trials.
  • HHS funding cancellation for bird flu vaccine development may impact Moderna's revenue streams.
  • Regulatory delays could slow down Moderna's product pipeline and affect its competitive edge.

What makes Moderna unique

  • Moderna is pioneering mRNA technology as a new class of medicines.
  • The company collaborates with IBM Quantum to enhance mRNA drug design using quantum computing.
  • Moderna's AI-driven research partnership with Benchling highlights its innovative approach to drug discovery.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Sick Leave

Paid Holidays

Sabbatical Leave

Hybrid Work Options

401(k) Company Match

Parental Leave

Family Planning Benefits

Fertility Treatment Support

Adoption Assistance

Wellness Program

Mental Health Support

Phone/Internet Stipend

Home Office Stipend

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

1%

2 year growth

4%
Meet the People
Jun 2nd, 2025
Social Media Campaign of the Year - Healthcare Marketing Impact Awards

Meet The People, LLC is delighted to share that Coegi's SpikevaxPartner campaign with Moderna has been recognized as a Social Media Campaign of the Year in the 2024 Healthcare Marketing Impact Awards by Modern Healthcare and Ad Age!

The Washington Post
May 28th, 2025
HHS cancels funding for Moderna to develop vaccines to combat bird flu

HHS cancels funding for Moderna to develop vaccines to combat bird flu.

FermionIQ
May 20th, 2025
Quantum-centric workflows for predicting RNA secondary structure

In a recent collaboration with Moderna and IBM Quantum, Fermioniq developed two quantum-centric optimization algorithms to predict mRNA secondary structure - a key challenge in computational biology with direct implications for mRNA-based drug design.

Things of Business
May 7th, 2025
Benchling and Moderna Collaborate on AI-Driven Research

SAN FRANCISCO and BOSTON, May 7, 2025 - Benchling, the R&D platform powering the biotech industry, today announced an expanded collaboration with Moderna.

Parriva
May 6th, 2025
Flesh-Eating Bacteria Surge in California: What You Need to Know

Moderna is reportedly working on a candidate vaccine using similar mRNA technology to its COVID-19 formula, but experts express concern about regulatory delays.

INACTIVE